Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1993
10/28/1993WO1993020849A1 Low toxicity interleukin-2 analogues for use in immunotherapy
10/28/1993WO1993020843A1 Oral treatment of helicobacter infection
10/28/1993WO1993020842A1 Suppression of proliferative response and induction of tolerance with polymorphic class ii mhc allopeptides
10/28/1993WO1993020841A1 Antibodies specific for carcinoma-associated antigens
10/28/1993WO1993020839A2 Use of renin-angiotensin antagonist for reducing post myocardial infarct mobidity and mortality
10/28/1993WO1993020838A1 Method and compositions for treatment of pyonecrotic processes
10/28/1993WO1993020837A1 Remedy for wound
10/28/1993WO1993020836A1 Treating disorders by application of insulin-like growth factors and analogs
10/28/1993WO1993020835A1 Treatment of hepatitis with gm-csf
10/28/1993WO1993020834A1 Methods and compositions for oral delivery of therapeutic agents
10/28/1993WO1993020833A1 Pharmaceutical composition containing cyclosporin derivative
10/28/1993WO1993020831A1 Method of treatment of hiv-seropositive individuals with dietary whey proteins
10/28/1993WO1993020830A1 Monocyte adhesion protein and monoclonal antibody thereto
10/28/1993WO1993020803A1 Method and composition for the treatment of disorders involving immunological dysfunction
10/28/1993WO1993020696A1 Regulation of the immune system
10/28/1993WO1993019089A3 Oxygen carrier
10/28/1993WO1993018148A3 Tumor necrosis factor with modified channel activity
10/28/1993WO1993018059A3 L-thiazolidine-4-carboxylic acid derivative, processes for the preparation thereof and the use thereof in therapy
10/28/1993WO1993016719A3 Use of platelet derived growth factor in ophthalmic wound healing
10/28/1993WO1993016713A3 Use of muramyl peptide for the treatment of toxicity
10/28/1993WO1993014206A3 Synthetic peptides for a rubella vaccine
10/28/1993WO1993009222A3 Transfection of vertebrate cells e.g. by homologous recombination
10/28/1993CA2388198A1 Adrenocorticotropic hormone receptor and uses
10/28/1993CA2133749A1 Suppression of t-cell proliferation using peptide fragments of myelin basic protein
10/28/1993CA2133659A1 Pyrimidinyl acetamides as elastase inhibitors
10/28/1993CA2133658A1 Heterocyclic derivatives
10/28/1993CA2133657A1 Substituted derivatives
10/28/1993CA2133090A1 Endothelin antagonists ii
10/28/1993CA2132543A1 Lactam dipeptides having hle inhibiting activity
10/28/1993CA2131166A1 Peptides having a gdp exchange factor activity, nucleic acid sequences coding for said peptides, preparation and utilization
10/28/1993CA2118503A1 Peptides having tachykinin antagonist activity
10/28/1993CA2118502A1 Supression of proliferative response and induction of tolerance with polymorphic class ii mhc allopeptides
10/28/1993CA2118253A1 Tachiquinine antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds
10/28/1993CA2118250A1 Lactam peptides having hle inhibiting activity
10/28/1993CA2118028A1 Ultrapure human epidermal growth factor
10/28/1993CA2117780A1 Cartillage matrix protein and methods for use
10/28/1993CA2117779A1 T cell epitopes of the major allergens from ambrosia artemisifolia
10/28/1993CA2117747A1 A novel hyaluronan receptor protein and novel hyaluronan binding peptides
10/28/1993CA2111189A1 Oral treatment of helicobacter infection
10/28/1993CA2110911A1 Treating disorders by application of insulin-like growth factors and analogs
10/28/1993CA2094835A1 Stimulator for bone formation
10/27/1993EP0567448A1 Factor VIII preparation
10/27/1993EP0567391A1 A biodegradable tgf-beta delivery system for bone regeneration
10/27/1993EP0567324A1 Medicaments for treating gar-transformylase-dependent tumors
10/27/1993EP0567216A1 Composition comprising omega-3 fatty acid source and glutathione stimulator for the treatment of immunedisorders and viral infections
10/27/1993EP0567100A1 Mutant respiratory syncytial virus (RSV) vaccines containing same and methods of use
10/27/1993EP0567088A2 Processes for the preparation of amylase inhibitor
10/27/1993EP0566919A1 2,4-dioxoimidazoline derivatives
10/27/1993EP0566732A1 Adeno-associated virus-2 basal vectors
10/27/1993EP0566698A1 Amino-substituted pyrimidines, derivatives and methods of use therefor
10/27/1993EP0566673A1 Biosynthetic pdgf antagonists
10/27/1993EP0566647A1 Improved humanized immunoglobulins
10/27/1993EP0566630A1 Process for the synthesis and purification of human ciliary neuronotrophic factor (cntf) from escherichia coli
10/27/1993EP0566596A1 Increased expression by a second transferred sequence in transgenic organisms
10/27/1993EP0394349B1 Wound healing
10/26/1993US5256771 Heat treatment of IgM-containing immunoglobulins to eliminate non-specific complement activation
10/26/1993US5256770 Oxidation resistant thrombomodulin analogs
10/26/1993US5256766 Recombinant thrombin receptor and related pharmaceuticals
10/26/1993US5256684 Methods and compositions for the treatment of gastrointestinal disorders
10/26/1993US5256677 Enzyme inhibitor for treating acquired immune deficiency syndrome
10/26/1993US5256651 Hydrophilic-hydrophobic derivatives of polygalactomannans containing tertiary amine functionality
10/26/1993US5256644 Applying a mixture of somatomedins and transforming growth factor
10/26/1993US5256643 For diagnosis of colorectal and breast cancers
10/26/1993US5256642 Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
10/26/1993US5256641 Covalent polar lipid-peptide conjugates for immunological targeting
10/26/1993US5256640 Protein, fat, carbohydrates
10/26/1993US5256560 Suspension of mammalian, non-murine, non-human cells comprised of pluripotent lymphohematopoietic non-adherent progenitor stem cells which produce primitive cell colony stimulating factors
10/26/1993US5256559 Storing the platelets in a solution of synthetic hirudin peptides antiagglomerants
10/26/1993US5256546 Plasmid which upon introduction into bacterial host renders host capable of effecting expression of growth hormone
10/26/1993US5256534 CD4+, latently HIV-1-infected hematopoietic progenitor cells
10/26/1993US5256412 Plasma protein modified to negative moiety
10/26/1993US5256411 Immune cell proliferation inhibitors
10/26/1993US5256410 Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon
10/26/1993US5256409 Complexing two drug haptens to carrier protein
10/26/1993US5256140 Composition for levelling skin
10/26/1993CA1323728C Human gamma interferon-specific receptor protein, antibody against said protein, methods for obtaining said protein and said antibody and compositions containing said protein and antibody
10/26/1993CA1323567C Method for purification of antibodies
10/25/1993CA2094797A1 Method of treating and preventing viral infections using hbnf and mk protein
10/25/1993CA2093836A1 Biodegradable tgf-.beta. delivery system for bone regeneration
10/24/1993CA2094687A1 Method of treating gar-transformylase-dependent tumors
10/24/1993CA2094311A1 Method of reducing or preventing toxicity associated with antiretroviral therapy
10/21/1993CA2093735A1 Amyloid precursor-like protein and uses thereof
10/20/1993EP0566542A1 Use of L-carnitine or acyl-L-carnitine in combination with an ACE-inhibitor for producing pharmaceutical composition for the treatment of cardiovascular disorders
10/20/1993EP0566410A2 Derivatives of adipogenesis inhibitory factor, their preparation and their use
10/20/1993EP0566237A2 Retroviral protease inhibitors
10/20/1993EP0566158A1 The use of alpha-1-antitrypsin mutants in the manufacture of medicaments, and therapeutic formulations using mutants and their preparation
10/20/1993EP0566157A1 Neutral metalloendopeptidase inhibitors in the treatment of hypertension
10/20/1993EP0566135A1 Transmucosal composition comprising a peptide and a cytidine derivative
10/20/1993EP0565896A2 Derivatives of aspartic acid, preparation and use thereof
10/20/1993EP0565722A1 Pharmaceutical preparation for pernasal administration
10/20/1993EP0565642A1 Method of preventing inflammatory damage
10/20/1993EP0565634A1 Angiotensin ii receptor blocking compositions
10/20/1993EP0565626A1 Fusions of a viral protein and a destructive enzyme
10/20/1993EP0565618A1 Stabilization of proteins by cationic biopolymers
10/20/1993EP0565604A1 Drug delivery system
10/20/1993EP0565536A1 Stabilized, potent grf analogs
10/20/1993EP0563389A4 Pharmaceutical aerosol preparation and its use for treatment and prophylaxis of viral diseases
10/20/1993EP0533795A4 Composition of and treatment with biologically active peptides having d-amino acid residues
10/20/1993EP0529065A4 Receptor-based screening methods for amylin agonists and antagonists
10/20/1993EP0458930B1 STABILIZATION OF GLYCOSYLIZED t-PA
1 ... 2918 2919 2920 2921 2922 2923 2924 2925 2926 2927 2928 2929 2930 2931 2932 2933 2934 2935 2936 2937 2938 ... 3163